Oncology Drug Research, Development, and Manufacturing
Source: Roche Brother
On April 11, Roche sent an email notification:
Announcement Regarding Ms. Chen Yanli, Vice President of Human Resources and Organizational Culture at Roche Pharmaceuticals China, and Head of Key Hospital Accounts for Market Access in China.
Dear Colleagues,
We regret to announce to everyone,Ms. Chen Yanli, Vice President of Talent and Organizational Culture at Roche Pharmaceuticals China and Head of the Key Account Management Department for Hospital Market Access in China, will leave the company on April 28, 2024, to pursue external development opportunities.
Ms. Chen Yanli joined Roche in 2019 and led several transformation projects, making positive contributions to business development, talent, and organizational culture building.She focuses on business goals, organizational capabilities, and leadership development, and has implemented Roche Pharmaceuticals' talent strategy in China.With a passion for talent development, Ms. Chen Yanli has driven the achievement of talent development goals through cross-functional and cross-team collaboration. In 2022, Ms. Chen expanded her responsibilities to also serve as the Head of Hospital Key Account Management for Market Access in China. Over the past two years, she has optimized the value proposition for hospital key accounts, integrated multi-party resources, and proactively responded to evolving business needs, achieving remarkable results.
Let us all wish Ms. Chen Yanli a smooth journey ahead!
For this important position, we will announce the job recruitment information in the near future and actively seek an excellent successor.






